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The growing increase in age-related hearing loss (ARHL), with its dramatic reduction
in quality of life and significant increase in health care costs, is a catalyst to develop
new therapeutic strategies to prevent or reduce this aging-associated condition. In this
regard, there is extensive evidence that excessive free radical formation along with
diminished cochlear blood flow are essential factors involved in mechanisms of other
stress-related hearing loss, such as that associated with noise or ototoxic drug exposure.
The emerging view is that both play key roles in ARHL pathogenesis. Therapeutic
targeting of excessive free radical formation and cochlear blood flow regulation may be
a useful strategy to prevent onset of ARHL. Supporting this idea, micronutrient-based
therapies, in particular those combining antioxidants and vasodilators like magnesium
(Mg2+), have proven effective in reducing the impact of noise and ototoxic drugs in the
inner ear, therefore improving auditory function. In this review, the synergistic effects of
combinations of antioxidant free radicals scavengers and cochlear vasodilators will be
discussed as a feasible therapeutic approach for the treatment of ARHL.
Keywords: antioxidants, vitamins, cochlear blood flow, magnesium, oxidative stress, presbyacusis, sensorineural
hearing loss
Introduction
Despite the fact that age-related hearing loss (ARHL) affects more than one-third of the
world population over 60 years-old, rising to more than two-third of those in their 70’s
(Ohlemiller and Frisina, 2008; Gopinath et al., 2009; Lin et al., 2011; Yamasoba et al., 2013),
currently there is no available medical treatment for this age-related sensory dysfunction.
This has led to an important humanitarian cost in terms of isolation, frustration, depression,
cognitive decline and decrease in quality of life (World Health Organization, 2002, 2013;
Huang and Tang, 2010; Kidd III and Bao, 2012; Ciorba et al., 2012), along with an enormous
and growing economic burden in health care costs (World Health Organization, 2002, 2013;
Huang and Tang, 2010). In an attempt to address this issue, recent research has focused on
understanding the cellular mechanisms that participate in the development and progression of
ARHL, in order to refine its diagnosis and facilitate the design of new therapeutic strategies
to prevent or reduce this sensory impairment and it consequences. Animal models have been
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valuable tools for the evaluation of this complex and
multifactorial condition; and have provided significant
information on the underlying genetic, molecular, histological
and physiological factors associated with ARHL (Syka, 2002,
2010; Ohlemiller, 2006; Bielefeld et al., 2008, 2010; Fetoni et al.,
2011; Alvarado et al., 2014). Previous studies have demonstrated
that similar to that which occurs in other stress-related auditory
pathologies, such as noise and drug-induced hearing loss (Ames
et al., 1993; Ohlemiller, 2006; Chen et al., 2009; Bielefeld et al.,
2010; Huang and Tang, 2010; Fetoni et al., 2011; Haider et al.,
2014), an excess of free radical formation and blood flow
reduction in the cochlea may be critical factors in triggering
hearing loss associated with aging (Seidman et al., 2002; Bielefeld
et al., 2010; Fetoni et al., 2011; Fujimoto and Yamasoba, 2014).
Free Radical Formation and Blood Flow
Reduction in Cochlea
As part of normal cellular homeostasis, free radicals, notably
reactive oxygen species (ROS), are continuously generated
during aerobic respiration as by-products of redox reactions,
mostly in mitochondria (Ames et al., 1993; Chen et al., 2009;
Bielefeld et al., 2010; Huang and Tang, 2010; Fujimoto and
Yamasoba, 2014). Free radicals are unstable molecular species
that contain one or more unpaired electrons, which make them
highly reactive (Halliwell, 2006; Halliwell and Gutteridge, 2007).
It is noteworthy, that although all oxygen radicals are ROS, not
all ROS are oxygen radicals, leading researchers to distinguish
between oxygen non-radical species and reactive radical/non-
radical species (e.g., reactive nitrogen species, reactive bromide
species, and reactive chlorine species) (for a detailed summary of
ROS, see Halliwell, 2006; Halliwell and Gutteridge, 2007). Under
normal conditions, adequate intracellular ROS levels are essential
to regulate many cell signaling pathways (Finkel, 2012; Ray et al.,
2012; Sena and Chandel, 2012) and cellular homeostasis (Sena
and Chandel, 2012), among other cellular functions. However,
as a consequence of imbalances in production of free radicals
and endogenous antioxidant systems, ROS concentrations may
increase, become toxic, and cause oxidative stress-induced
cell damage (Ames et al., 1993; Halliwell, 2006; Halliwell and
Gutteridge, 2007; Chen et al., 2009; Sena and Chandel, 2012;
Böttger and Schacht, 2013; Fujimoto and Yamasoba, 2014). As
ROS-induced reactions proceed, other excessive free radicals,
such as nitric monoxide, peroxide, superoxide, hydroxyl or
peroxyl radicals (Ames et al., 1993; Seidman et al., 2002; Halliwell,
2006; Halliwell and Gutteridge, 2007; Uttara et al., 2009; Park
and Yeo, 2013; Fujimoto and Yamasoba, 2014), interact causing
oxidative damage of lipids and proteins in cell membranes and
the cytosol, mitochondrial and nuclear genome mutations, and
ultimately lead to cellular death (Ames et al., 1993; Uttara et al.,
2009; Lee and Wei, 2012; Fujimoto and Yamasoba, 2014).
As postulated for several neurodegenerative diseases such
as amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and
Huntington’s diseases (Ames et al., 1993; Lin and Beal, 2006),
the cascade of molecular events related to ROS overproduction
may play a crucial role during the aging process (Ames et al.,
1993; Ohlemiller, 2006; Chen et al., 2009; Bielefeld et al., 2010;
Huang and Tang, 2010; Fetoni et al., 2011; Fujimoto and
Yamasoba, 2014; Haider et al., 2014; Ortuño-Sahagún et al.,
2014). Specifically, an excess of free radicals in the cochlear
sensory epithelium, spiral ganglion neurons and cells of the
stria vascularis may have a relevant role in the development
of ARHL (Figures 1A–D; Ohlemiller, 2006; Chen et al., 2009;
Bielefeld et al., 2010; Huang and Tang, 2010; Fetoni et al., 2011;
Fujimoto and Yamasoba, 2014). Of importance, excessive ROS
build up is clearly the key factor in the pathogenesis of other
stress-induced otological conditions that also result in reduced
auditory function, such as noise and drug induced hearing loss
(Figure 1E; Ohinata et al., 2003; Le Prell et al., 2007a,b, 2014;
Bielefeld et al., 2010; Fetoni et al., 2011). These findings provide
the rationale to support the hypothesis that therapeutic strategies
targeting ROS overproduction may be potentially useful not only
for ameliorating noise and drug induced hearing loss but also
to improve ARLH. Thus we propose that excessive free radical
formationmay provide a ‘‘common pathogenic pathway’’, shared
by these pathologies (Figure 1E).
In addition to free radical generation in the cochlea, reduction
in cochlear blood flow and vascular conductance during aging is
another main contributor to cochlear damage. Consistent with
this notion, during senescence there is a significant decrease in
the circulating blood volume with reductions that may reach
up to 20% in the cerebral flow (Park and Yeo, 2013). Despite
the strong autoregulation of cochlear blood flow that occurs
under normal conditions, the cochlea is no exception to this
rule, as a significant decrease in blood flow regulation as well as
in blood supply to the cochlea occurs during aging, particularly
in the stria vascularis, in a number of animal models and
man (Johnsson and Hawkins, 1972; Schuknecht and Gacek,
1993; Nakashima, 1999; Seidman et al., 1999; Seidman, 2000;
Shi, 2011). Age-related alterations in the microvasculature of
the stria vascularis, virtually the only vascularized epithelium
in the body, have been found to correlate with the increase
in auditory thresholds observed in presbyacusis, a condition
known as strial or ‘‘metabolic’’ presbyacusis (Schuknecht and
Gacek, 1993), as well as in noise and drug induced hearing
loss, (Boettcher, 2002; Bielefeld et al., 2010; Fetoni et al.,
2011; Shi, 2011; Lee, 2013; Ruan et al., 2014). The stria
vascularis is pivotal in maintaining the endocochlear potential
(EP; Figure 1F) as alterations in its structure and function
induce a progressive decrease in the EP, finally affecting the
cochlear amplification of acoustic signals (Gates and Mills,
2005; Schmiedt, 2010). Thus, diminished cochlear blood flow
may contribute to damage to the stria vascularis and altered
hair cell function (with or without cell death) and to aging-
related increases in auditory thresholds (Shi, 2011; Lee, 2013).
It is worth noting that recent evidence shows that there is
a significant involvement of strial presbyacusis in the genesis
of the ARHL, leading to the suggestion that alterations in
the stria vascularis could be the major cause of hearing loss
during aging (Schuknecht and Gacek, 1993; Gates and Mills,
2005; Schmiedt, 2010; Clinkard et al., 2013; Lee, 2013). In
line with these observations, pharmacological up-regulation
of cochlear blood flow could provide a vital treatment for
ARHL.
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FIGURE 1 | Cochlear damage results in imbalances in free radical
formation and cochlear blood supply in the inner ear following noise
overstimulation, ototoxic drugs and aging. (A–D) Confocal images show
target cochlear structures affected by oxidative stress and reduced CBF: the
StV and SL (B), outer and inner hair cells (arrows in C) and the SG (D). Dashed
line in (B) outlines the StV. Filamentous actin was stained with Phalloidin (green)
and cell nuclei with caspase (red) and DAPI (blue). (E) Excessive ROS along
with reduced CBF lead to oxidative stress-induced cell damage causing
disruption of the inner ear structure and function. (F) Injury to the stria vascularis
induces a dysregulation of the EP (blue arrows) that affects K(+) concentration,
which in addition to diminished CBF, results in sensory epithelium disruption.
Abbreviations: ROS, reactive oxygen species; CBF, cochlear blood flow; EP,
endocochlear potential; SV, scala vestibuli; SM, scala media; ST, scala tympani;
StV, stria vascularis; SL, spiral ligament; SG, spiral ganglion; TM, tectorial
membrane; OHC, outer hair cells; IHC inner hair cell. Scale bars: 100 µm in (A);
50 µm in (B–D).
Free Radical Scavengers and Vasodilators
In the cell, there are different and overlapping antioxidant
systems of defense against oxidative stress. The enzymatic
systems involved include superoxide dismutase, glutathione
peroxidase, glutathione reductase and catalases while the
non-enzymatic scavengers are vitamins and micronutrients
(Figures 2A,B; Halliwell, 2006; Halliwell and Gutteridge, 2007).
As an excess of free radical formation is likely involved in the
pathogenesis of many types of hearing loss, the administration
of antioxidants has been used to minimize or avoid inner ear
damage in conditions such as noise and drug induced hearing
loss (Yamasoba et al., 1999; Seidman et al., 2002; Ohinata et al.,
2003; Yamashita et al., 2005; Le Prell et al., 2007a, 2011; Fetoni
et al., 2011). Although there is still controversy about the benefits
of using free radical scavengers for the treatment of ROS induced
cochlear damage (Uttara et al., 2009; Bielefeld et al., 2010; Park
and Yeo, 2013), most studies seem to agree that antioxidants
reduce structural and functional stress-induced pathology in
the inner ear in experimental animals (Yamasoba et al., 1999;
Ohinata et al., 2003; Yamashita et al., 2005; Le Prell et al.,
2007b; Bielefeld et al., 2010; Fetoni et al., 2011). For instance,
mannitol (Yamasoba et al., 1999), N-acetylcysteine (Kopke et al.,
2005, 2007), acetyl-L-carnitine (Kopke et al., 2005), sallicylates
combined with N-acetylcysteine (Kopke et al., 2000, 2005), trolox
(Yamashita et al., 2005) or vitamins A, C, and E (Le Prell et al.,
2007a, 2011) attenuate inner ear damage following noise-induce
hearing loss. Similarly, D-methionine (Campbell et al., 2007), N-
acetylcysteine (Tokgoz et al., 2011) or a combination of vitamins
A, C, and E (Le Prell et al., 2014) also have been shown to protect
the cochlea after drug ototoxicity.
This growing body of evidence supports the use of
antioxidants to ameliorate pathological related to excess ROS. A
clear example of this is the prevention and interruption of ROS-
induced lipid peroxidation in cell membranes by vitamins A, C,
and E (Figures 2A,B; Halliwell, 2006; Halliwell and Gutteridge,
2007). Given the key role of ROS in ARHL (Ohlemiller, 2006;
Chen et al., 2009; Bielefeld et al., 2010; Huang and Tang, 2010;
Fetoni et al., 2011; Fujimoto and Yamasoba, 2014), it is likely
that free radical scavengers may provide a pharmacological
approach to treat presbyacusis. Supporting this expectation the
administration of resveratrol (Seidman et al., 2003) or L-carnitine
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FIGURE 2 | Effects of micronutrients on oxidative stress and cochlea
vasculature. (A) Increased ROS generation induced by noise, drugs, aging
and even low extracellular Mg2+, may lead to oxidative DNA damage and lipid
peroxidation in the cell membrane. The non-enzymatic antioxidant system,
which is composed by micronutrients such as Vit E, Vit C, and β-Car
(metabolized to form Vit A) can block and/or revert lipid peroxidation, by
reducing the impact of oxidative stress. (B) In response to ROS
overproduction, peroxyl radicals of lipids (LOO·) and alkoxyl radicals of lipids
(LO·) can be generated from polyunsaturated fatty acids (PUFA) of the cell
membrane phospholipids. Both radicals can be scavenged by Vit E, one of
the major antioxidants in the cell membrane. On the other hand, Vit C,
considered one of the most important antioxidant molecules in the
extracellular fluid, in addition to scavenging ROS, it can also protect cell
membranes by regenerating Vit E from the oxidized form (Vit E·). Thus, the
functions of both Vit E and Vit C in lipid peroxidation are coupled. Finally, the
antioxidant activity of β-Car may also contribute to protect membranes from
lipid peroxidation by scavenging LOO·. The reaction product (LO2-β-Car·) can
react in turn with an oxygen molecule to generate a new peroxyl radical
(LO2-β-Car-O2·). (C) A byproduct of free radical formation in the inner ear
(8-Iso-Prostaglandin F2α) is a powerful vasoconstrictor; and thus reduced
blood flow is found with intense noise exposure, which may be blocked by an
isoprostane blocker or a cochlear vasodilator, such as Mg2+. Similarly Mg2+
will increase inner ear blood flow in the vascularly compromised aging ear.
(Continued)
FIGURE 2 | Continued
Abbreviations: ROS, reactive oxygen species; Vit A, vitamin A; Vit E, vitamin E;
Vit C, vitamin C; β-Car, β-Carotene; Mg2+, magnesium; O2·-, superoxide
radical; OH·, hydroxyl radicals.
(Derin et al., 2004) in Fischer 344 andWistar rats respectively, or
a combination of L-cysteine-glutathione mixed disulfide, ribose-
cysteine, NW-nitro-L-arginine methyl ester, vitamin B12, folate,
and ascorbic acid in C57BL/6 mice (Heman-Ackah et al., 2010)
led to improved auditory function and delayed onset of ARHL.
In possible contradiction, the administration of either vitamin
C in senescent marker protein 30/gluconolactonase knockout
mice, which cannot synthesize vitamin C (Kashio et al., 2009),
N-acetyl-L-cysteine in the C57BL/6J mouse strain (Davis et al.,
2007) or a combination of vitamins A, C, and E, L-carnitine
and α-lipoic-enriched diet in CBA/J mice (Sha et al., 2012)
did not improve auditory function or reduce ARHL. Negative
results are of course more difficult to interpret. They may be
due to inadequate dosing or to species differences or to the
different experimental conditions used for the administration of
antioxidants. Also, targeting a single factor responsible for the
pathogenesis of the ARHL may not be sufficient to avoid or
reduce the effects of aging on hearing.
Given the fact that strial presbyacusis could be at the origin of
most forms of ARHL (Schuknecht and Gacek, 1993; Gates and
Mills, 2005; Schmiedt, 2010; Clinkard et al., 2013; Lee, 2013),
and that this pathology is caused at least in part by alterations
in the microvasculature and decreased strial blood flow, the use
of cochlear vasodilators to improve auditory thresholds during
aging seems a reasonable option. Indirectly supporting this idea,
the administration of hydrogen sulfide as a vasodilator following
noise-induced hearing loss has been proven to have a protective
effect on the inner ear as it reduces cochlear damage and
improves auditory function (Li et al., 2011). A similar positive
response on hearing was observed when using hydroxyethyl
starch but not when pentoxifylline was administered in guinea
pigs after noise trauma (Lamm and Arnold, 2000). As opposed
to these latter findings, a recent study in guinea pigs concluded
that the administration of pentoxifylline after noise overexposure
produced a near-normal auditory brainstem response and
reduced the damage to the organ of Corti (Kansu et al., 2011).
Another potential cochlear vasodilator that has been used as
otoprotector is Mg2+ (Figure 2C). Pharmacological properties
of this cation include increased cochlear blood flow (Haupt and
Scheibe, 2002), modulation of the NMDA glutamate receptor,
regulation of influx of calcium into the sensory hair cells and
also calcium channel permeability (Günther et al., 1989; Cevette
et al., 2003; Le Prell et al., 2007b). The effectiveness of magnesium
in protecting the cochlea from noise insult has been shown
in guinea pigs (Ising et al., 1982; Scheibe et al., 2000; Miller
et al., 2003; Le Prell et al., 2007a), CBA/J mice (Le Prell et al.,
2011) and humans (Attias et al., 1994). Of relevance, magnesium
has a greater otoprotective effect after noise trauma in CBA/J
mice when coupled to free radical scavengers than that observed
when either magnesium or antioxidants are used individually
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as micronutrients (Le Prell et al., 2007a). Indeed together their
protective effect is significantly greater than the sum of the
individual agent protective effects. A similar combination of
micronutrients has been demonstrated to reduce gentamicin-
induced ototoxicity, reducing the threshold shift for frequencies
at 12 kHz and below and protecting inner and outer hair cells
in the upper half of the cochlea (Le Prell et al., 2014). As
presbyacusis shares physiopathological alterations with noise and
drug induced hearing loss, vasodilators like Mg2+ may protect
the inner ear during aging (Figure 2C). Nonetheless, despite the
benefits of using vasodilators for the treatment of hearing loss,
as described in this review, there are no studies to date that
have assessed its effects either individually or in combination on
ARHL.
Conclusions
In the light of evidence presented in this review, focused on the
key roles of free radicals and reduced blood flow in pathogenesis
of stress-induced hearing loss, we propose that a combined
therapy targeting these specific factors, which are well implicated
in the genesis and/or progression of presbyacusis, may attenuate
ear damage and therefore, improve auditory function during
aging. While there is not yet an effective medication to prevent
a multifactorial and complex pathological condition such as
ARHL, a treatment based on the synergistic effects of natural
micronutrients such as the antioxidants vitamins A, C and E and
the vasodilator magnesium all with good safety profiles, seems to
be an excellent and promising efficacious therapeutic alternative
for the treatment of this sensory impairment associated with
aging.
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